Decoy Therapeutics (DCOY) Proxy Filing summary

Executive summary

• Annual meeting scheduled for December 20, 2024, with voting open until December 19, 2024 at 11:59 PM ET.

• Shareholders can vote online, by phone, email, or in person at the virtual meeting.

• Meeting materials are available online, with options to request paper or email copies.

Voting matters and shareholder proposals

• Election of two directors: Tess Burleson and Paul Lammers, both recommended by the board.

• Advisory vote to approve executive compensation for named executive officers.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2024.

• Other business may be addressed as appropriate during the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of both director nominees.